Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
9.51
+0.09 (0.96%)
At close: May 11, 2026, 4:00 PM EDT
9.59
+0.08 (0.84%)
After-hours: May 11, 2026, 7:44 PM EDT
Kura Oncology Market Cap
Kura Oncology has a market cap or net worth of $844.13 million as of May 11, 2026. Its market cap has increased by 62.55% in one year.
Market Cap
844.13M
Enterprise Value
209.78M
1-Year Change
62.55%
Ranking
Category
Stock Price
$9.51
Market Cap Chart
Since November 5, 2015, Kura Oncology's market cap has increased from $113.70M to $844.13M, an increase of 642.42%. That is a compound annual growth rate of 21.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 832.10M | -7.96% |
| Dec 31, 2025 | 904.10M | 33.49% |
| Dec 31, 2024 | 677.30M | -36.58% |
| Dec 29, 2023 | 1.07B | 28.64% |
| Dec 30, 2022 | 830.20M | -10.90% |
| Dec 31, 2021 | 931.80M | -49.69% |
| Dec 31, 2020 | 1.85B | 197.24% |
| Dec 31, 2019 | 623.10M | 16.69% |
| Dec 31, 2018 | 534.00M | 15.51% |
| Dec 29, 2017 | 462.30M | 266.61% |
| Dec 30, 2016 | 126.10M | -29.75% |
| Dec 31, 2015 | 179.50M | 57.87% |
| Nov 5, 2015 | 113.70M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Geron | 914.17M |
| Alpha Tau Medical | 893.30M |
| ARS Pharmaceuticals | 887.75M |
| CytomX Therapeutics | 887.10M |
| Evommune | 884.25M |
| Janux Therapeutics | 883.66M |
| Aura Biosciences | 879.11M |
| Arbutus Biopharma | 874.41M |